Professor Ruth Roberts, Co-Founder and Director of ApconiX will be speaking at the American Association of Pharmaceutical Scientists (AAPS) on Monday 4th November at 9:00am in a session entitled “Next Generation Technologies in Preclinical Development” chaired by Dr Shraddha Thakkar from the US FDA. Ruth’s talk is entitled “Science-Driven Design of the Preclinical Package: Case by Case”. Ruth is also a panellist with Dr Weida Tong (FDA) and Dr Thomas Hartung (Johns Hopkins University) on “AI Driven Alternative Methods for Drug Safety and Efficacy” on Wed 6th November.
“It’s going to be a great meeting and I am looking forward to some very lively discussions with Drs Tong and Hartung”, commented Ruth.
AAPS PharmSci 360 is taking place between the 3rd and 7th of November at the Henry B. Gonzalez Convention Center in San Antonio, Texas.
Founded in 1986, the American Association of Pharmaceutical Scientists is a professional, scientific organisation of approximately 7,000 individual members and over 10,000 active participants employed in academia, industry, government, and other pharmaceutical science related research institutes worldwide.
APS PharmSci 360 combines all the energy of a large scientific conference with the intimacy of a niche meeting covering all aspects of pharmaceutical sciences from Preclinical Development, Bioanalytics, Clinical Pharmacology, Manufacturing & Bioprocessing and Formulation & Quality. With more than 6000 attendees expected, there will be the opportunity to explore 1,700+ peer-reviewed posters and 100+ exhibitors on the trade show floor, as well as numerous workshops, talks and short courses. Read more about the APS PharmSci 360 programme